We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




bioMérieux and NuGEN Enter Licensing Agreement

By Labmedica staff writers
Posted on 21 May 2007
bioMérieux (Marcy l'Etoile, France) and NuGEN Technologies, Inc. More...
(San Carlos, CA, USA) have announced an agreement to cross-license intellectual property, as well as a supply agreement for NuGEN's exclusive WT-Ovation RNA amplification system. Financial details were not disclosed.

The agreement gives bioMérieux non-exclusive rights to specific NuGEN amplification technologies, which will enable bioMérieux to create and market in vitro diagnostic (IVD) tests requiring amplification for expression analysis.

In return, NuGEN will gain access to bioMérieux linear amplification technologies using chimeric primers, including extensive original equipment manufacturer (OEM) rights for the research market. As a result, NuGEN will be able to broaden its substantial intellectual property portfolio in this area.

The dual accord will enable bioMérieux to integrate NuGEN technologies for the development of a highly sensitive and automatable microarray-based assay for cancer with the objective to increase test easy-of-use and to reduce the time from sample acquisition to diagnosis.

NuGEN's whole transcriptome approach, in combination with our linear amplification technologies, further enhances our amplification capabilities,” explained Peter Kaspar, bioMérieux corporate vice president of research and development. WT-Ovation technology will enable us to develop and commercialize standardized IVD solutions for oncology that can be used nimbly in a clinical setting. Ultimately, this new system will reduce the time between sample acquisition and critical diagnosis, allowing physicians to make important and personalized decisions about a patient's therapy.


Related Links:
NuGEN Technologies, Inc.
bioMérieux

New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.